World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
135
Citations
90464
World Ranking
2026
National Ranking
1149

Overview

Charles M. Rudin is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on medical fields, with significant contributions in medicine and biochemistry, genetics, and molecular biology.

The scientist has published extensively in subfields including oncology, molecular biology, pulmonary and respiratory medicine, cancer research, and epidemiology. Their work covers numerous topics, with key areas including lung cancer research studies, lung cancer treatments and mutations, neuroendocrine tumor research advances, cancer genomics and diagnostics, peptidase inhibition and analysis, cancer immunotherapy and biomarkers, and RNA modifications related to cancer.

Recent papers authored or co-authored by Charles M. Rudin include the following:

  • Small-cell lung cancer, 2021, Nature Reviews Disease Primers
  • Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study, 2020, Journal of Clinical Oncology

Their frequent coauthors include:

  • Àlvaro Quintanal-Villalonga
  • Elisa de Stanchina
  • Triparna Sen
  • John T. Poirier
  • Natasha Rekhtman

Charles M. Rudin has contributed to multiple scientific venues, most often publishing in the Journal of Clinical Oncology, followed by Cancer Research, Journal of Thoracic Oncology, bioRxiv (Cold Spring Harbor Laboratory), and Clinical Cancer Research.

Best Publications

  • Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

    H. Borghaei;L. Paz-Ares;L. Horn;D. R. Spigel

  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

    Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann

  • Akt stimulates aerobic glycolysis in cancer cells

    Rebecca L. Elstrom;Daniel E. Bauer;Monica Buzzai;Robyn Karnauskas

  • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski

  • Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

    Aleksandar Sekulic;Michael R. Migden;Anthony E. Oro;Luc Dirix

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

    Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann

  • Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

    Hira Rizvi;Francisco Sanchez-Vega;Konnor La;Walid Chatila

  • Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma

    Daniel D. Von Hoff;Patricia M. LoRusso;Charles M. Rudin;Josina C. Reddy

  • Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449

    Charles M. Rudin;Christine L. Hann;John Laterra;Robert L. Yauch

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Ayuko Hoshino;Ayuko Hoshino;Han Sang Kim;Han Sang Kim;Linda Bojmar;Linda Bojmar;Linda Bojmar;Kofi Ennu Gyan

  • Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.

    Federico Innocenti;Samir D. Undevia;Lalitha Iyer;Pei Xian Chen

  • Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

    Matthew D. Hellmann;Tavi Nathanson;Hira Rizvi;Benjamin C. Creelan

  • Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

    Charles M Rudin;Steffen Durinck;Eric W Stawiski;John T Poirier

  • Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

    Jarushka Naidoo;Xuan Wang;Xuan Wang;Xuan Wang;Kaitlin M. Woo;Kaitlin M. Woo;Tunc Iyriboz;Tunc Iyriboz

  • Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma

    Robert L. Yauch;Gerrit J. P. Dijkgraaf;Bruno Alicke;Thomas Januario

  • Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.

    Charles M. Rudin;John T. Poirier;Lauren Averett Byers;Caroline Dive

  • Small-cell lung cancer.

    Charles M. Rudin;Elisabeth Brambilla;Corinne Faivre-Finn;Julien Sage

  • Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer

    Rosalyn A. Juergens;John Wrangle;Frank P. Vendetti;Sara C. Murphy

  • DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration

    Hiroki Kaneko;Sami Dridi;Valeria Tarallo;Bradley D. Gelfand

  • LUNG CANCER IN NEVER SMOKERS: CLINICAL EPIDEMIOLOGY AND ENVIRONMENTAL RISK FACTORS

    Jonathan M. Samet;Erika Avila-Tang;Paolo Boffetta;Lindsay M. Hannan

Frequent Co-Authors

Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
John T. Poirier
John T. Poirier New York University Langone Medical Center
Matthew D. Hellmann
Matthew D. Hellmann Memorial Sloan Kettering Cancer Center
Gregory J. Riely
Gregory J. Riely Memorial Sloan Kettering Cancer Center
Maria E. Arcila
Maria E. Arcila Memorial Sloan Kettering Cancer Center
Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
Alexander Drilon
Alexander Drilon Memorial Sloan Kettering Cancer Center
Natasha Rekhtman
Natasha Rekhtman Memorial Sloan Kettering Cancer Center
David B. Solit
David B. Solit Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA can open doors to a wide range of online health-related degrees and career pathways. For example, students interested in preventive care and health promotion might consider an online BS in nutrition to build a strong foundation in nutritional science without needing to attend campus classes.

If you see yourself in healthcare management or hospital administration, online mha programs cahme accredited offer flexibility for working professionals who want to enhance their leadership skills.

Registered Nurses (RNs) looking to advance in their careers can explore rn to bsn online without clinicals programs. These pathways provide advancement opportunities while accommodating busy work schedules, and often do not require physical clinical placements.

For those aiming for the highest level of practice in nursing, the fastest online dnp programs can help you become a Doctor of Nursing Practice more efficiently, keeping your studies streamlined.

These online alternatives cater to a range of interests, making healthcare careers more accessible for diverse learners.

Best Scientists Citing Charles M. Rudin

Trending Scientists

Recently Published Articles